Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Weigel

Showing results (371-380 of 423) with videos related to

Pageof 43
Sort By:
Blood|June 24, 2010
Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemiaQing Zhou, Meghan E Munger, Steven L Highfill, et al.
Cancer Medicine|January 21, 2021
Phase 1 trial of olaratumab monotherapy and in combination with chemotherapy in pediatric patients with relapsed/refractory solid and central nervous system tumorsLeo Mascarenhas, Chitose Ogawa, Theodore W Laetsch, et al.
Cancer|September 11, 2020
ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma-A Children's Oncology Group studyJames I Geller, Joseph G Pressey, Malcolm A Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2019
Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312)Kristina A Cole, Sharmistha Pal, Rachel A Kudgus, et al.
Oncotarget|February 1, 2018
Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancerJames P De Andrade, Allison W Lorenzen, Vincent T Wu, et al.
Oncogene|January 29, 2014
TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesisA R Cyr, M V Kulak, J M Park, et al.
Journal of the American College of Surgeons|January 27, 2026
Surgical Trainee Familiarity and Knowledge of the Commission on Cancer (CoC) Operative Standards: A National Survey StudyAlison S Baskin, Elizabeth C Funk, Jack W Sample, et al.
Molecular Cancer Research : MCR|October 18, 2019
A <i>TFAP2C</i> Gene Signature Is Predictive of Outcome in HER2-Positive Breast CancerVincent T Wu, Boris Kiriazov, Kelsey E Koch, et al.
Mbio|September 22, 2023
The <i>Candida albicans</i> reference strain SC5314 contains a rare, dominant allele of the transcription factor Rob1 that modulates filamentation, biofilm formation, and oral commensalismVirginia E Glazier, Juraj Kramara, Tomye Ollinger, et al.
Cancers|November 13, 2025
Reclassifying Menopausal Breast Cancer and Assessing Non-Genetic Risk Factors in Ghanaian Women: Insights from a Cohort StudyClaudia Adzo Anyigba, Victor Ayinbora Azusiyine, Courage Siame, et al.
Pageof 43

Showing results (371-380 of 423) with videos related to

Sort By:
Pageof 43
Blood|June 24, 2010
Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemiaQing Zhou, Meghan E Munger, Steven L Highfill, et al.
Cancer Medicine|January 21, 2021
Phase 1 trial of olaratumab monotherapy and in combination with chemotherapy in pediatric patients with relapsed/refractory solid and central nervous system tumorsLeo Mascarenhas, Chitose Ogawa, Theodore W Laetsch, et al.
Cancer|September 11, 2020
ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma-A Children's Oncology Group studyJames I Geller, Joseph G Pressey, Malcolm A Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2019
Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312)Kristina A Cole, Sharmistha Pal, Rachel A Kudgus, et al.
Oncotarget|February 1, 2018
Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancerJames P De Andrade, Allison W Lorenzen, Vincent T Wu, et al.
Oncogene|January 29, 2014
TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesisA R Cyr, M V Kulak, J M Park, et al.
Journal of the American College of Surgeons|January 27, 2026
Surgical Trainee Familiarity and Knowledge of the Commission on Cancer (CoC) Operative Standards: A National Survey StudyAlison S Baskin, Elizabeth C Funk, Jack W Sample, et al.
Molecular Cancer Research : MCR|October 18, 2019
A <i>TFAP2C</i> Gene Signature Is Predictive of Outcome in HER2-Positive Breast CancerVincent T Wu, Boris Kiriazov, Kelsey E Koch, et al.
Mbio|September 22, 2023
The <i>Candida albicans</i> reference strain SC5314 contains a rare, dominant allele of the transcription factor Rob1 that modulates filamentation, biofilm formation, and oral commensalismVirginia E Glazier, Juraj Kramara, Tomye Ollinger, et al.
Cancers|November 13, 2025
Reclassifying Menopausal Breast Cancer and Assessing Non-Genetic Risk Factors in Ghanaian Women: Insights from a Cohort StudyClaudia Adzo Anyigba, Victor Ayinbora Azusiyine, Courage Siame, et al.
Pageof 43